FI970667L - Koostumukset - Google Patents

Koostumukset Download PDF

Info

Publication number
FI970667L
FI970667L FI970667A FI970667A FI970667L FI 970667 L FI970667 L FI 970667L FI 970667 A FI970667 A FI 970667A FI 970667 A FI970667 A FI 970667A FI 970667 L FI970667 L FI 970667L
Authority
FI
Finland
Prior art keywords
physiologically tolerable
manganese
alpha
compositions
hydroxy
Prior art date
Application number
FI970667A
Other languages
English (en)
Swedish (sv)
Other versions
FI970667A7 (fi
FI970667A0 (fi
Inventor
Klaes Golman
Goeran Pettersson
Arne Berg
Jo Klaveness
Paol Rongved
Peter Leander
Ib Leunbach
Wolfgang Gunther
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416767A external-priority patent/GB9416767D0/en
Priority claimed from GB9416768A external-priority patent/GB9416768D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Priority claimed from PCT/GB1995/001969 external-priority patent/WO1996005867A2/en
Publication of FI970667L publication Critical patent/FI970667L/fi
Publication of FI970667A7 publication Critical patent/FI970667A7/fi
Publication of FI970667A0 publication Critical patent/FI970667A0/fi

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
FI970667A 1994-08-18 1995-08-18 Koostumukset FI970667A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9416767A GB9416767D0 (en) 1994-08-18 1994-08-18 Compositions
GB9416768A GB9416768D0 (en) 1994-08-18 1994-08-18 Compositions
PCT/GB1995/001969 WO1996005867A2 (en) 1994-08-18 1995-08-18 Compositions

Publications (3)

Publication Number Publication Date
FI970667L true FI970667L (fi) 1997-02-17
FI970667A7 FI970667A7 (fi) 1997-02-17
FI970667A0 FI970667A0 (fi) 1997-02-17

Family

ID=26305478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970667A FI970667A0 (fi) 1994-08-18 1995-08-18 Koostumukset

Country Status (6)

Country Link
EP (1) EP0776219A2 (fi)
JP (1) JPH10504559A (fi)
AU (1) AU688565B2 (fi)
CA (1) CA2197466A1 (fi)
FI (1) FI970667A0 (fi)
NZ (1) NZ291479A (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980863A (en) * 1998-11-02 1999-11-09 Eagle Vision Pharmaceutical Corporation Manganese compositions and methods for MRI
EP3980081A1 (en) * 2019-06-07 2022-04-13 Ascelia Pharma AB Compressed solid composition for mri

Also Published As

Publication number Publication date
EP0776219A2 (en) 1997-06-04
JPH10504559A (ja) 1998-05-06
CA2197466A1 (en) 1996-02-29
AU3262095A (en) 1996-03-14
FI970667A7 (fi) 1997-02-17
FI970667A0 (fi) 1997-02-17
NZ291479A (en) 1999-04-29
AU688565B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
EE04223B1 (et) Interferooni stabiilne vedelkompositsioon, mis sisaldab aminohappeid
PL319833A1 (en) Compounds and composition for carrying active media
FI964473A0 (fi) Uudet aminohappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset (II)
PT93245A (pt) Processo para a preparacao de novos derivados de glicina e de composicoes farmaceuticas que os contem
CA1262862C (en) TETRAPYRROLE THERAPEUTIC AGENTS
FI941987L (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
CA2296036A1 (en) Dolastatin 15 derivatives
DK0862634T3 (da) Farmaceutisk præparat mod papillomavirustumorer og -infektioner
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
DK0637334T3 (da) Peptider med en GDP-udskiftningsfaktoraktivitet, nukleinsyresekvenser, der koder for disse peptider, fremstilling og anvendelse
GEP20012516B (en) Tricyclic Compounds Having Activity Specific for Integring, Particularly , avB3 Integrins, Method for Preparation the Same as Drugs and Pharmaceutical Composition Containing Same
WO1996005867A3 (en) Compositions
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
FI970667L (fi) Koostumukset
DE69406853D1 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE68906572D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69901088D1 (de) 1,2-Dithiolan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
ES2162086T3 (es) Diamidas acidas aromaticas con actividad antigastrina, un metodo para su preparacion y su uso farmaceutico.
DE69412980D1 (de) Eburnan-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0115850A3 (en) Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide
FI951988A7 (fi) Neurokiniinien uudet pseudopeptidiyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ES2000182A6 (es) Procedimiento para la obtencion de (iso) ureas substituidas potenciadoras del rendimiento.
ATE95169T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
IL114646A (en) Pharmaceutical compositions containing phenylurea derivatives for inhibiting leukotriene biosynthesis